Written by Tasha Ann Miller
November 20, 2020
Pfizer and BioNTech are seeking approval from the United States Food and Drug Administration (FDA) to authorize emergency use of their Covid19 vaccine.
This emergency approval is critical as there is a continued rise in Covid19 cases in American. The multinational companu, Pfizer in partnership with BioNTech recently announced that their vaccines has a 95% success rate against the Covid19 virus.
The company is now undergoing the movement of vaccines to four US states (Tennesse, Rhode Island, Texas, and New Mexico) for trial. Pfizer’s partnership with BioNTech is one of the leading vaccination success in the fight to end the pandemic. Other companies like Moderna also reported a 94.5% effective vaccine. In China, the vaccine development and distribution has been largely unregulated by offical authorities like the World Health Organization (WHO), and people are reportedly receiving vaccines that are still going through testing.
Therefore, this clearly indicates that there will be several vaccines on the market once they are officially approved for distribution.
Pfizer and BioNTech’s vaccine is still unapproved for use outside of clinical trials. The Hope Vision will continue to monitor the latest updates on the progress of the varying stages, and urges you all to continue to stay safe.